Outrun Therapeutics
Outrun Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Seed, 1 tracked investor.
About Outrun Therapeutics
Based in the United Kingdom, Outrun Therapeutics is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Outrun Therapeutics is a preclinical biotech using E3 ligase inhibition to unlock the therapeutic potential of protein stabilisation for the treatment of cancer and other diseases. Its proprietary platform has generated multiple programmes, with the lead programme being a small molecule inhibitor targeting an E3 ligase that destabilises a tumour suppressor protein in hard-to-treat solid tumours.
Explore Outrun Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.